GRIN2A and schizophrenia: Our conclusion is that selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B genes of NMDA-R do not seem to be associated with both resistance to schizophrenia treatment with clozapine, and also with the occurrence of cognitive disturbances in schizophrenia.